Biovie BIVI
NASDAQ BIVI
$1.46 -0.01 (-0.68%)
At close: Oct 2, 2026 · 4:00 PM EDT

Biovie (BIVI) Cash from Investing Activities (2023)

Updated

Biovie (BIVI) recorded Cash from Investing Activities of $14.53 million in FY2024 (year ended Jun 30, 2024), compared with -$14.3 million in FY2023.

Analysis

Biovie (BIVI) Cash from Investing Activities (2023) Analysis & Trends

  • Per Business Quant data, BIVI's Cash from Investing Activities was -$14.3 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -15.40 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -1.11 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -5.60 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.11 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -2.91 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -569.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -10.35 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.11 Bn
10 Biovie 11.01 Mn 11.01 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 14.53 Mn
Jun 30, 2023 -1.80 Mn
API Access

Biovie Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=BIVI&period=max&api_key=YOUR_API_KEY